======= SPTLC2 ======= == Gene Information == * **Official Symbol**: SPTLC2 * **Official Name**: serine palmitoyltransferase long chain base subunit 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9517|9517]] * **UniProt**: [[https://www.uniprot.org/uniprot/O15270|O15270]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SPTLC2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SPTLC2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605713|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a long chain base subunit of serine palmitoyltransferase. Serine palmitoyltransferase, which consists of two different subunits, is the key enzyme in sphingolipid biosynthesis. It catalyzes the pyridoxal-5-prime-phosphate-dependent condensation of L-serine and palmitoyl-CoA to 3-oxosphinganine. Mutations in this gene were identified in patients with hereditary sensory neuropathy type I. [provided by RefSeq, Mar 2011]. * **UniProt Summary**: Serine palmitoyltransferase (SPT). The heterodimer formed with LCB1/SPTLC1 constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2-SPTSSA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC2-SPTSSB complex displays a preference for C18-CoA substrate. {ECO:0000269|PubMed:19416851, ECO:0000269|PubMed:20920666}. |Aminotran 1 2| |sphinganine biosynthetic process| |sphinganine metabolic process| |serine C-palmitoyltransferase complex| |positive regulation of lipophagy| |serine C-palmitoyltransferase activity| |regulation of lipophagy| |sphingomyelin biosynthetic process| |sphingosine biosynthetic process| |sphingoid biosynthetic process| |sphingosine metabolic process| |sphingomyelin metabolic process| |sphingoid metabolic process| |diol biosynthetic process| |diol metabolic process| |adipose tissue development| |ceramide biosynthetic process| |pyridoxal phosphate binding| |polyol biosynthetic process| |positive regulation of macroautophagy| |ceramide metabolic process| |sphingolipid biosynthetic process| |polyol metabolic process| |alcohol biosynthetic process| |positive regulation of autophagy| |membrane lipid biosynthetic process| |sphingolipid metabolic process| |regulation of macroautophagy| |organic hydroxy compound biosynthetic process| |ammonium ion metabolic process| |membrane lipid metabolic process| |connective tissue development| |phospholipid biosynthetic process| |alcohol metabolic process| |regulation of autophagy| |positive regulation of cellular catabolic process| |phospholipid metabolic process| |positive regulation of catabolic process| |organic hydroxy compound metabolic process| |amide biosynthetic process| |organophosphate biosynthetic process| |lipid biosynthetic process| |small molecule biosynthetic process| |cellular amide metabolic process| |regulation of cellular catabolic process| |organophosphate metabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |regulation of catabolic process| |lipid metabolic process| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |tissue development| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp47|Lapatinib 5μM R01 exp47]]|-4.08| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-3.75| |[[:results:exp17|DABN 20μM R00 exp17]]|-3.71| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|-3.69| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|-3.59| |[[:results:exp79|Q15 2.7μM R02 exp79]]|-3.52| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-3.31| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-3.22| |[[:results:exp538|ZLN024 50μM R08 exp538]]|-3.18| |[[:results:exp90|WYE-354 6μM R02 exp90]]|-3.04| |[[:results:exp169|BH1 1μM R04 exp169]]|-2.85| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|-2.82| |[[:results:exp495|IWR1 50μM R08 exp495]]|-2.64| |[[:results:exp149|SB203580 25μM R03 exp149]]|-2.38| |[[:results:exp67|BVD-523 15μM R02 exp67]]|-2.3| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-2.29| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-2.15| |[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|-2.11| |[[:results:exp461|BS-181 20μM R08 exp461]]|-2.06| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|-2.01| |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|-1.99| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.94| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-1.94| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|-1.93| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.92| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|-1.89| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|-1.88| |[[:results:exp151|SGC0946 7μM R03 exp151]]|-1.81| |[[:results:exp469|CFI-400945 25μM R08 exp469]]|-1.76| |[[:results:exp536|Vitamin-D3 40μM R08 exp536]]|-1.74| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|1.72| |[[:results:exp512|Olaparib 4μM R08 exp512]]|1.82| |[[:results:exp264|Arsenate 40μM R06 exp264]]|1.94| |[[:results:exp447|Amiloride 100μM R08 exp447]]|2.12| ^Gene^Correlation^ |[[:human genes:s:sptlc1|SPTLC1]]|0.634| |[[:human genes:s:sptssa|SPTSSA]]|0.55| |[[:human genes:c:chka|CHKA]]|0.467| |[[:human genes:c:col4a3bp|COL4A3BP]]|0.465| |[[:human genes:f:flvcr1|FLVCR1]]|0.46| |[[:human genes:c:cept1|CEPT1]]|0.454| |[[:human genes:p:pi4kb|PI4KB]]|0.435| |[[:human genes:c:c10orf76|C10orf76]]|0.429| |[[:human genes:v:vkorc1l1|VKORC1L1]]|0.424| |[[:human genes:w:wdr7|WDR7]]|0.421| |[[:human genes:s:scap|SCAP]]|0.413| |[[:human genes:m:mbtps1|MBTPS1]]|0.403| Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5491 * **Expression level (log2 read counts)**: 6.84 {{:chemogenomics:nalm6 dist.png?nolink |}}